Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8750
Corporate User License Price USD 375
Corporate User License Price INR 26250
Site License Price USD 250
Site License Price INR 17500
Request a Quote

Report Title

Heron Therapeutics Inc (HRTX)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Heron Therapeutics Inc (HRTX)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Heron Therapeutics Inc (HRTX)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Heron Therapeutics Inc (HRTX)-Financial and Strategic SWOT Analysis Review



Executive Summary

Heron Therapeutics Inc (HRTX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-based drug delivery platform, which improves the therapeutic profile of injectable pharmaceuticals. The company's first commercial product Sustol is an extended-release injection indicated in combination with other antiemetics in adults for the prevention of moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. Heron's developmental pipeline includes HTX-011 for post-operative pain management and Cinvanti (HTX-019) for chemotherapy-induced nausea and vomiting (CINV) prevention. Heron is headquartered in San Diego, California, the US.

Heron Therapeutics Inc Key Recent Developments

Feb 23,2017: Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Progress

Nov 08,2016: Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress

Aug 08,2016: Heron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress

Aug 02,2016: Heron Therapeutics Enters into Loan Agreement for Up to $100 Million

Jun 22,2016: Heron Therapeutics Announces Appointment of Christian Waage to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Heron Therapeutics Inc-Key Facts 6

Heron Therapeutics Inc-Key Employees 7

Heron Therapeutics Inc-Key Employee Biographies 8

Heron Therapeutics Inc-Major Products and Services 9

Heron Therapeutics Inc-Pharmaceutical Pipeline Products Data 10

Heron Therapeutics Inc, Pipeline Products by Therapy Area 10

Heron Therapeutics Inc, Pipeline Products by Development Phase 10

Heron Therapeutics Inc-History 12

Heron Therapeutics Inc-Company Statement 14

Heron Therapeutics Inc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

Heron Therapeutics Inc-Business Description 16

Heron Therapeutics Inc-Corporate Strategy 17

Heron Therapeutics Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

Heron Therapeutics Inc-Strengths 18

Heron Therapeutics Inc-Weaknesses 19

Heron Therapeutics Inc-Opportunities 20

Heron Therapeutics Inc-Threats 21

Heron Therapeutics Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30

Heron Therapeutics Inc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Feb 23, 2017: Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Progress 32

Nov 08, 2016: Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress 33

Aug 08, 2016: Heron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress 34

Jun 22, 2016: Heron Therapeutics Announces Appointment of Christian Waage to Board of Directors 35

May 05, 2016: Heron Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Progress 36

Mar 17, 2016: Heron Therapeutics Appoints David L. Szekeres, SVP Business Development, General Counsel and Corporate Secretary 37

Feb 19, 2016: Heron Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results and Recent Corporate Progress 38

Jan 28, 2016: Heron Therapeutics Appoints Kimberly J. Manhard as Executive Vice President of Drug Development 39

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Tables

Heron Therapeutics Inc, Key Facts 6

Heron Therapeutics Inc, Key Employees 7

Heron Therapeutics Inc, Key Employee Biographies 8

Heron Therapeutics Inc, Major Products and Services 9

Heron Therapeutics Inc, Number of Pipeline Products by Development Stage 11

Heron Therapeutics Inc, History 12

Heron Therapeutics Inc, Other Locations 15

Heron Therapeutics Inc, Key Competitors 22

Heron Therapeutics Inc, Ratios based on current share price 23

Heron Therapeutics Inc 24

Heron Therapeutics Inc (Cont...1) 25

Heron Therapeutics Inc, Interim Ratios 27

Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30

Heron Therapeutics Inc, Recent Deals Summary 31

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

List of Figures

Heron Therapeutics Inc, Pipeline Products by Therapy Area 10

Heron Therapeutics Inc, Pipeline Products by Development Phase 10

Heron Therapeutics Inc, Performance Chart (2012-2016) 26

Heron Therapeutics Inc, Ratio Charts 28

Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29

Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

ProStrakan Group plc Pacira Pharmaceuticals Inc Hospira Inc GlaxoSmithKline Plc F. Hoffmann-La Roche Ltd Eisai Co Ltd DURECT Corp

Heron Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person